AI-generated summary
The authors report a meta-analysis of five randomised controlled trials, including 139 patients, comparing the 755-nm picosecond alexandrite laser with conventional treatments for melasma. They found that triple combination cream reduced MASI scores more than the laser, and post-inflammatory hyperpigmentation was more common with the laser than with topical creams. Certainty was low because the trials were small and heterogeneous.
- Participants
- 139
- Studies included
- 5
- Who or what was studied
- Adults with melasma
- Wavelengths
- 755 nm
- Limits stated in the abstract
- The authors state that overall certainty is low due to small, heterogeneous trials and that longer RCTs with larger samples are needed.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Meta-analysis, Systematic review, Risk of bias, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.